SFGate notes that a South Korean team has been permitted to proceed with therapeutic cloning and embryonic stem cell research: "[the] team of scientists who produced the first cloned human embryo last year were given government approval Wednesday to proceed with stem-cell research to find cures for diabetes, cerebral palsy and Parkinson's and other diseases -- but not for work toward reproductive human cloning ... scientists hope this research will one day allow them to grow replacement tissue to treat spinal cord injuries as well as diabetes and other diseases." That teams outside the US are forging ahead makes it less likely that the US goverment will be able to shut down this very promising research.
Link: http://www.sfgate.com/cgi-bin/article.cgi?file=/news/archive/2005/01/12/financial1028EST0076.DTL